
Sign up to save your podcasts
Or
The editors also review two recently licensed drugs: eluxadoline, a mixed opioid receptor agonist/antagonist for irritable bowel syndrome (http://dtb.bmj.com/content/55/8/90) and an oral formulation of glycopyrronium (http://dtb.bmj.com/content/55/8/93) for severe drooling in children.
4.8
44 ratings
The editors also review two recently licensed drugs: eluxadoline, a mixed opioid receptor agonist/antagonist for irritable bowel syndrome (http://dtb.bmj.com/content/55/8/90) and an oral formulation of glycopyrronium (http://dtb.bmj.com/content/55/8/93) for severe drooling in children.
83 Listeners
2,083 Listeners
39 Listeners
51 Listeners
94 Listeners
8 Listeners
5 Listeners
3 Listeners
2 Listeners
4 Listeners
9 Listeners
38 Listeners
14 Listeners
1 Listeners
51 Listeners
0 Listeners
6 Listeners
14 Listeners
85 Listeners
3 Listeners
21 Listeners
3 Listeners
26 Listeners
24 Listeners
140 Listeners
50 Listeners
11 Listeners
9 Listeners
21 Listeners
5 Listeners
5 Listeners
97 Listeners